Photo taken from Shannon Westin/X
Mar 26, 2024, 09:45
Shannon Westin: Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer
Shannon Westin, Professor at Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X/Twitter:
“Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer – 31% reduction in risk of death consistent with 16 month improvement!!!”
Source: Shannon Westin/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53
Apr 19, 2025, 17:17